Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma
Clinical trial NCT05993299 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05993299
- Sponsor
- USWM, LLC (dba US WorldMeds)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-31
- Primary completion
- 2022-10-12
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.